Liver function tests and hepatitis B virus (HBV) DNA (Versant 3.0) were assessed bimonthly, whereas adefovir-related mutations were searched by INNO-LiPA assay at baseline and at yearly intervals.
In this retrospective multi center analysis we studied the effectiveness of TDF monotherapy in patients with HBV monoinfection with respect to virologic parameters and resistance.